Literature DB >> 6282440

Spontaneous regression of hepatocellular carcinoma: a case study.

K C Lam, J C Ho, R T Yeung.   

Abstract

A Chinese patient with documented hepatocellular carcinoma (HCC) satisfied the criteria of Everson and Cole for spontaneous regression of malignant tumors. Subsequently he survived a tumor-free period of at least 13 years. During the period of regression, shrinkage of liver coincided with a rise of SGOT to a level comparable to that reported for patients with liver cancer during hepatic arterial ligation and cytotoxic therapy. Postregression liver biopsy from the site of the previous tumor revealed relatively uninflamed HBsAg-positive tissue without dysplasia. The case provided the positive end of the survival spectrum in HCC, evidence that regression of HCC might occur by involution rather than maturation, and histologic data suggesting that regressed HCC might be replaced by surrounding tissue instead of leaving behind dysplasia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6282440     DOI: 10.1002/1097-0142(19820715)50:2<332::aid-cncr2820500228>3.0.co;2-o

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  17 in total

Review 1.  Spontaneous regression of hepatocellular carcinoma: three case reports and a categorized review of the literature.

Authors:  Susana Oquiñena; Mercedes Iñarrairaegui; Juan J Vila; Felix Alegre; Jose M Zozaya; Bruno Sangro
Journal:  Dig Dis Sci       Date:  2008-08-21       Impact factor: 3.199

Review 2.  Spontaneous regression of hepatocellular carcinoma: report of a case.

Authors:  Hiroshi Ohtani; Osamu Yamazaki; Mitsuharu Matsuyama; Katsuhiko Horii; Sadatoshi Shimizu; Hiroko Oka; Hiroko Nebiki; Kiyohide Kioka; Osamu Kurai; Yasuko Kawasaki; Takao Manabe; Katsuko Murata; Ryoichi Matsuo; Takeshi Inoue
Journal:  Surg Today       Date:  2005       Impact factor: 2.549

3.  Clear cell hepatocellular carcinoma with spontaneous regression of primary and metastatic lesions.

Authors:  Seong-Woo Jeon; Myung-Kwon Lee; Young-Doo Lee; Hyang-Eun Seo; Chang-Min Cho; Won-Young Tak; Young-Oh Kweon
Journal:  Korean J Intern Med       Date:  2005-09       Impact factor: 2.884

4.  Spontaneous regression of hepatocellular carcinoma.

Authors:  R C Ayres; D A Robertson; K C Dewbury; G H Millward-Sadler; C L Smith
Journal:  Gut       Date:  1990-06       Impact factor: 23.059

Review 5.  Spontaneous regression of a recurrent hepatocellular carcinoma.

Authors:  R Gómez Sanz; E Moreno Gonzalez; F Colina Ruiz-Delgado; H Garcia-Muñoz; F Ochando Cerdan; I Gonzalez-Pinto
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

6.  Spontaneous regression of hepatocellular carcinoma repeated 3 times with invasion of portal vein and inferior vena cava: report on a rare case.

Authors:  Hirokazu Komatsu; Satoshi Imamura; Tomoki Shimizu; Yuya Tsunoda; Tsuyoshi Ito; Jin Imai; Shuichi Nagakubo; Yuichi Morohoshi; Yuriko Fujita
Journal:  Clin J Gastroenterol       Date:  2011-12-09

7.  Spontaneous regression of hepatocellular carcinoma.

Authors:  Shunsuke Kondo; Takuji Okusaka; Hideki Ueno; Masafumi Ikeda; Chigusa Morizane
Journal:  Int J Clin Oncol       Date:  2006-10       Impact factor: 3.402

8.  Recurrence of hepatocellular carcinoma with rapid growth after spontaneous regression.

Authors:  Tomoki Nakajima; Michihisa Moriguchi; Tadashi Watanabe; Masao Noda; Nobuaki Fuji; Masahito Minami; Yoshito Itoh; Takeshi Okanoue
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 9.  Spontaneous Regression of Hepatocellular Carcinoma with Multiple Lung Metastases: A Case Report and Review of the Literature.

Authors:  Eirini Pectasides; Rebecca Miksad; Sergey Pyatibrat; Amogh Srivastava; Andrea Bullock
Journal:  Dig Dis Sci       Date:  2016-04-01       Impact factor: 3.199

10.  Hepatocellular Carcinoma Regression After Cessation of Immunosuppressive Therapy.

Authors:  Abhijeet Kumar; Dung T Le
Journal:  J Clin Oncol       Date:  2014-09-22       Impact factor: 44.544

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.